David Berman
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOCORE HOLDINGS PLC
Vermögen: - $ am 30.04.2024
Aktive Positionen von David Berman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | - |
Karriereverlauf von David Berman
Ehemalige bekannte Positionen von David Berman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2015 | 01.01.2018 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2015 | 01.01.2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2005 | 01.01.2015 |
Ausbildung von David Berman
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Börse
- Insiders
- David Berman
- Erfahrung
